Clinical Trials: SEARCH[STUDY] TILT[STUDY:STUDY-FIRST-POSTED] ALL
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 6181 6182 6183 6184 6185 6186 6187 6188 6189 6190 6191 6192 6193 6194 6195 6196 6197 6198 6199 6200 6201 6202 6203 6204 6205 6206 6207 6208 6209 6210 6211 6212 6213 6214 6215 6216 6217 6218 6219 6220 6221 … 6265 6266 6267 6268 6269 6270 6271 6272 6273 6274 6275 6276 6277 6278 6279 6280 6281 6282 6283 6284 Next Last
#
NCTID/Status
Study
Last Changed
310001
NCT00034749
Completed
Completed
The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia
Conditions: Schizophrenia
Intervention: Risperidone
Conditions: Schizophrenia
Intervention: Risperidone
June 6, 2011
310002
NCT00034736
Completed
Completed
A Study to Compare the Efficacy and Safety of Levofloxacin in the Treatment of Children With Community-acquired Pneumonia in the Hospital or Outpatient Setting
Conditions: Pneumonia
Intervention: Levofloxacin
Conditions: Pneumonia
Intervention: Levofloxacin
June 6, 2011
310003
NCT00034723
Completed
Completed
MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
Conditions: Tropical Spastic Paraparesis
Conditions: Tropical Spastic Paraparesis
March 3, 2008
310004
NCT00034710
Completed
Completed
Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain
Conditions: Neuralgia; Pain; Peripheral Nervous System Diseases; Herpes Zoster
Intervention: Capsaicin Patch
Conditions: Neuralgia; Pain; Peripheral Nervous System Diseases; Herpes Zoster
Intervention: Capsaicin Patch
February 6, 2006
310005
NCT00034697
Terminated
Terminated
Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)
Conditions: Metastases, Neoplasm; Carcinoma, Non-Small-Cell Lung; Brain Neoplasms
Intervention: Temozolomide
Conditions: Metastases, Neoplasm; Carcinoma, Non-Small-Cell Lung; Brain Neoplasms
Intervention: Temozolomide
May 22, 2017
310006
NCT00034684
Completed
Completed
Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)
Conditions: Leukemia; Myelodysplastic Syndromes; Leukemia, Myeloid, Chronic; Blast Crisis; Leukemia, Lymphocytic
Intervention: Farnesyl Protein Transferase Inhibitor
Conditions: Leukemia; Myelodysplastic Syndromes; Leukemia, Myeloid, Chronic; Blast Crisis; Leukemia, Lymphocytic
Intervention: Farnesyl Protein Transferase Inhibitor
June 16, 2015
310007
NCT00034671
Completed
Completed
PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)
Conditions: Mycoses
Intervention: Posaconazole Oral Suspension
Conditions: Mycoses
Intervention: Posaconazole Oral Suspension
December 30, 2015
310008
NCT00034658
Completed
Completed
Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)
Conditions: Mycoses
Intervention: Posaconazole
Conditions: Mycoses
Intervention: Posaconazole
March 7, 2017
310009
NCT00034645
Completed
Completed
Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease
Conditions: Mycoses
Intervention: Posaconazole Oral Suspension
Conditions: Mycoses
Intervention: Posaconazole Oral Suspension
March 7, 2017
310010
NCT00034632
Completed
Completed
Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)
Conditions: Mycoses
Intervention: Posaconazole Oral Suspension
Conditions: Mycoses
Intervention: Posaconazole Oral Suspension
March 7, 2017
310011
NCT00034619
Completed
Completed
A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.
Conditions: Colorectal Cancer
Intervention: ALIMTA, Oxaliplatin
Conditions: Colorectal Cancer
Intervention: ALIMTA, Oxaliplatin
July 18, 2006
310012
NCT00034606
Completed
Completed
Comparing 3 Schedules of Alimta Plus Gemzar
Conditions: Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Neoplasms
Intervention: Pemetrexed (Alimta) In Combination With Gemcitabine (Gemzar)
Conditions: Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Neoplasms
Intervention: Pemetrexed (Alimta) In Combination With Gemcitabine (Gemzar)
July 18, 2006
310013
NCT00034593
Completed
Completed
A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
Conditions: Urologic Neoplasms
Intervention: ALIMTA, Gemcitabine
Conditions: Urologic Neoplasms
Intervention: ALIMTA, Gemcitabine
July 18, 2006
310014
NCT00034580
Completed
Completed
Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
Conditions: Bipolar Disorder
Intervention: Olanzapine, Risperidone
Conditions: Bipolar Disorder
Intervention: Olanzapine, Risperidone
July 18, 2006
310015
NCT00034567
Completed
Completed
Healthy Aging and Memory Study
Conditions: Alzheimer Disease
Conditions: Alzheimer Disease
September 14, 2007
310016
NCT00034554
Completed
Completed
Study of gp75 Vaccine in Patients With Stage III and IV Melanoma
Conditions: Malignant Melanoma
Intervention: Gp75 DNA Vaccine
Conditions: Malignant Melanoma
Intervention: Gp75 DNA Vaccine
April 8, 2010
310017
NCT00034541
Completed
Completed
Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
Intervention: Cetuximab, Paclitaxel, Carboplatin
Conditions: Carcinoma, Non-Small-Cell Lung
Intervention: Cetuximab, Paclitaxel, Carboplatin
April 8, 2010
310018
NCT00034528
Terminated
Terminated
Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia
Conditions: Hemoglobinopathies; Anemia, Sickle Cell; Hemoglobin SC Disease; Thalassemia; Thalassemia Major
Intervention: Busulfan, Fludarabine, FK506, Prednisone
Conditions: Hemoglobinopathies; Anemia, Sickle Cell; Hemoglobin SC Disease; Thalassemia; Thalassemia Major
Intervention: Busulfan, Fludarabine, FK506, Prednisone
April 30, 2013
310019
NCT00034515
Completed
Completed
A Study in Adult and Pediatric Patients With Cystic Fibrosis
Conditions: Cystic Fibrosis
Intervention: Denufosol Tetrasodium (INS37217) Inhalation Solution
Conditions: Cystic Fibrosis
Intervention: Denufosol Tetrasodium (INS37217) Inhalation Solution
February 13, 2015
310020
NCT00034502
Completed
Completed
A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.
Conditions: Colorectal Cancer
Intervention: ALIMTA, Irinotecan
Conditions: Colorectal Cancer
Intervention: ALIMTA, Irinotecan
July 18, 2006
310021
NCT00034489
Completed
Completed
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.
Conditions: Breast Neoplasms
Intervention: Pemetrexed, Gemcitabine
Conditions: Breast Neoplasms
Intervention: Pemetrexed, Gemcitabine
July 18, 2006
310022
NCT00034476
Completed
Completed
A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis
Conditions: Sepsis
Intervention: SPLA2 Inhibitor
Conditions: Sepsis
Intervention: SPLA2 Inhibitor
July 18, 2006
310023
NCT00034463
Completed
Completed
ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer
Conditions: Metastases; Cancer
Intervention: ALIMTA, Folic Acid, Multi-vitamins
Conditions: Metastases; Cancer
Intervention: ALIMTA, Folic Acid, Multi-vitamins
July 18, 2006
310024
NCT00034450
Completed
Completed
August 17, 2006
310025
NCT00034437
Completed
Completed
Immune Response to Cytomegalovirus
Conditions: Cytomegalovirus Infections
Conditions: Cytomegalovirus Infections
March 3, 2008
310026
NCT00034424
Recruiting
Recruiting
Cause of Familial Testicular Cancer
Conditions: Testicular Cancer
Conditions: Testicular Cancer
December 22, 2018
310027
NCT00034398
Completed
Completed
Study of GABA-A Receptors in the Generation of Tics in Patients With Tourette's Syndrome
Conditions: Tourette Syndrome
Conditions: Tourette Syndrome
June 30, 2017
310028
NCT00034385
Completed
Completed
Valganciclovir to Prevent Cytomegalovirus Infection in Kidney and Kidney/Pancreas Transplant Recipients
Conditions: Kidney Trasplant
Intervention: Valganciclovir
Conditions: Kidney Trasplant
Intervention: Valganciclovir
June 30, 2017
310029
NCT00034372
Terminated
Terminated
Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma
Conditions: Ovarian Neoplasms
Intervention: Oregovomab
Conditions: Ovarian Neoplasms
Intervention: Oregovomab
December 13, 2007
310030
NCT00034359
Completed
Completed
Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment Naive Adults With Chronic Hepatitis B Virus Infection
Conditions: Hepatitis B, Chronic
Intervention: ACH-126, 443 (beta-L-Fd4C), Lamivudine, Placebo
Conditions: Hepatitis B, Chronic
Intervention: ACH-126, 443 (beta-L-Fd4C), Lamivudine, Placebo
February 18, 2014
310031
NCT00017862
Completed
Completed
Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome
Conditions: Hypereosinophilic Syndrome
Intervention: SCH55700
Conditions: Hypereosinophilic Syndrome
Intervention: SCH55700
March 3, 2008
310032
NCT00034346
Completed
Completed
ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)
Conditions: Non-Small Cell Lung Cancer; Neoplasm Metastasis; Lung Cancer
Intervention: ABX-EGF, Paclitaxel, Carboplatin
Conditions: Non-Small Cell Lung Cancer; Neoplasm Metastasis; Lung Cancer
Intervention: ABX-EGF, Paclitaxel, Carboplatin
December 20, 2007
310033
NCT00034333
Terminated
Terminated
Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer
Conditions: Carcinoma, Hepatocellular
Intervention: MTC-DOX For Injection
Conditions: Carcinoma, Hepatocellular
Intervention: MTC-DOX For Injection
June 23, 2005
310034
NCT00034307
Unknown status
Unknown status
Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension
Conditions: Pulmonary Hypertension
Intervention: Sitaxsentan Sodium
Conditions: Pulmonary Hypertension
Intervention: Sitaxsentan Sodium
June 23, 2005
310035
NCT00034294
Completed
Completed
A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea
Conditions: Clostridium Difficile-Associated Diarrhea; Clostridium Enterocolitis; Clostridium Difficile Diarrhea; Antibiotic-associated Colitis; Antibiotic-associated Diarrhea
Intervention: GT160-246
Conditions: Clostridium Difficile-Associated Diarrhea; Clostridium Enterocolitis; Clostridium Difficile Diarrhea; Antibiotic-associated Colitis; Antibiotic-associated Diarrhea
Intervention: GT160-246
March 4, 2015
310036
NCT00034281
Completed
Completed
Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2
Conditions: Breast Neoplasm; Pancreatic Neoplasm; Lung Neoplasm; Ovarian Neoplasm; Renal Neoplasm
Intervention: TAK-165
Conditions: Breast Neoplasm; Pancreatic Neoplasm; Lung Neoplasm; Ovarian Neoplasm; Renal Neoplasm
Intervention: TAK-165
January 31, 2012
310037
NCT00034268
Completed
Completed
A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
Intervention: LY900003
Conditions: Carcinoma, Non-Small-Cell Lung
Intervention: LY900003
July 18, 2006
310038
NCT00034255
Completed
Completed
Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients
Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
Intervention: INGAP Peptide
Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
Intervention: INGAP Peptide
June 23, 2005
310039
NCT00034203
Completed
Completed
Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.
Conditions: Rheumatoid Arthritis
Intervention: Efalizumab
Conditions: Rheumatoid Arthritis
Intervention: Efalizumab
June 23, 2005
310040
NCT00034190
Completed
Completed
Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma
Conditions: Colorectal Adenocarcinoma
Intervention: S-8184 Paclitaxel Injectable Emulsion
Conditions: Colorectal Adenocarcinoma
Intervention: S-8184 Paclitaxel Injectable Emulsion
June 2, 2009
310041
NCT00034177
Completed
Completed
Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium
Conditions: Urologic Neoplasms
Intervention: S-8184 Paclitaxel Injectable Emulsion, Experimental Arm: TOCOSOL Paclitaxel
Conditions: Urologic Neoplasms
Intervention: S-8184 Paclitaxel Injectable Emulsion, Experimental Arm: TOCOSOL Paclitaxel
June 2, 2009
310042
NCT00034242
Completed
Completed
High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration
Conditions: Spinocerebellar Degenerations
Intervention: High-dose Intravenous Immunoglobulin (IVIG)
Conditions: Spinocerebellar Degenerations
Intervention: High-dose Intravenous Immunoglobulin (IVIG)
March 3, 2008
310043
NCT00034229
Completed
Completed
Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression
Conditions: Bipolar Disorder
Intervention: Felbamate
Conditions: Bipolar Disorder
Intervention: Felbamate
March 3, 2008
310044
NCT00034216
Recruiting
Recruiting
Collection of Blood From Patients With Cancer
Conditions: Prostate Cancer; Breast Cancer; Colon Cancer; Lung Cancer; Liver Cancer
Conditions: Prostate Cancer; Breast Cancer; Colon Cancer; Lung Cancer; Liver Cancer
August 1, 2019
310045
NCT00034164
Completed
Completed
Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
Intervention: S-8184 Paclitaxel Injectable Emulsion
Conditions: Carcinoma, Non-Small-Cell Lung
Intervention: S-8184 Paclitaxel Injectable Emulsion
June 2, 2009
310046
NCT00034151
Completed
Completed
Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer
Conditions: Ovarian Cancer
Intervention: S-8184 Paclitaxel Injectable Emulsion
Conditions: Ovarian Cancer
Intervention: S-8184 Paclitaxel Injectable Emulsion
June 2, 2009
310047
NCT00034138
Terminated
Terminated
A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma
Conditions: Ovarian Neoplasms
Intervention: Oregovomab
Conditions: Ovarian Neoplasms
Intervention: Oregovomab
December 13, 2007
310048
NCT00034125
Completed
Completed
Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.
Conditions: Breast Neoplasms
Intervention: LY353381, Tamoxifen
Conditions: Breast Neoplasms
Intervention: LY353381, Tamoxifen
July 18, 2006
310049
NCT00034112
Completed
Completed
Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease
Conditions: Emphysema
Intervention: Osteopathic Manipulative Treatment
Conditions: Emphysema
Intervention: Osteopathic Manipulative Treatment
August 17, 2006
310050
NCT00034086
Completed
Completed
Study of Anti-HIV Therapy Intensification
Conditions: HIV Infections
Intervention: Lopinavir/Ritonavir, Lamivudine/Zidovudine, Tenofovir Disoproxil Fumarate, Pneumococcal Vaccine, Polyvalent (23-valent), Lamivudine, Stavudine, Zidovudine, Didanosine, Lyme Disease Vaccine Recombinant OspA, Haemophilus B Conjugate Vaccine
Conditions: HIV Infections
Intervention: Lopinavir/Ritonavir, Lamivudine/Zidovudine, Tenofovir Disoproxil Fumarate, Pneumococcal Vaccine, Polyvalent (23-valent), Lamivudine, Stavudine, Zidovudine, Didanosine, Lyme Disease Vaccine Recombinant OspA, Haemophilus B Conjugate Vaccine
May 17, 2012
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 6181 6182 6183 6184 6185 6186 6187 6188 6189 6190 6191 6192 6193 6194 6195 6196 6197 6198 6199 6200 6201 6202 6203 6204 6205 6206 6207 6208 6209 6210 6211 6212 6213 6214 6215 6216 6217 6218 6219 6220 6221 … 6265 6266 6267 6268 6269 6270 6271 6272 6273 6274 6275 6276 6277 6278 6279 6280 6281 6282 6283 6284 Next Last
Last Updated
The last updated date is the most recent date when changes to a clinical trial were
submitted to ClinicalTrials.gov. There is often a delay of a few days before the
updated trial is available on the clinical trials website.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
First Received
The first received date is the date when the clinical trial was first submitted
to ClinicalTrials.gov. There is often a delay of a few days before the
trial is available on the clinical trials website.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Safety Issue
If selected, restricts search results to those studies which have
an outcome measure designated as a safety issue. Note that this is a
poor estimate of the safety of a treatment or intervention, but it is
all we have now.
Funded By
Studies are supported by one or more organizations called sponsors.
Support includes contributions of facilities, expertise, and/or financial resources.
All sponsors in the database have been assigned one of the following organization types:
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
Study Phase
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Age Group
Studies may be designed for participants of particular ages:
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Gender
Searches can be restricted to studies which accept female or male participants.
Location Terms
If you are interested in a specific city (such as Los Angeles) or facility
name (such as the Mayo Clinic), enter it as a location term. Not all studies
include this level of detail, but if they do, this will find them.
Countries and States
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state.
Study IDs
Each trial is assigned one or more identification numbers by the institute, agency,
or organization sponsoring the trial. In addition, clinical trials assigns a
unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit.
Use this box to search for a trial by NCT identifier or any other study
identification numbers.
Examples:
Examples:
NCT00001789
97-h-0197
ia0006
actg 076
97-h-0197
ia0006
actg 076
Sponsor (Lead)
Use this box to specify the name of an institute, organization, or company that is
conducting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Sponsor/Collaborators
Use this box to specify institutes, organizations, or companies that are
conducting or otherwise supporting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Outcome Measures
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Outcome measures are used to evaluate trial results. For example, an obesity treatment
might be evaluated by a measure of weight loss after 6 months. Measures can also be used
to quantify side effects, such as number of myocardial infarctions,
number of patients with heart arrhythmia, number of suicides, etc.
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Interventions
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Conditions
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Study Type
There are three types of studies available in ClinicalTrials.gov:
There are three types of studies available in ClinicalTrials.gov:
Interventional:
Observational:
Expanded Access:
Studies where individuals are assigned to receive specific interventions.
Participants may receive diagnostic, therapeutic or other types of interventions.
Assignment of the intervention may or may not be random.
Individuals are tracked and biomedical and/or health outcomes are assessed.
Observational:
Studies without an intervention.
Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals.
Participants may receive diagnostic, therapeutic, or other interventions, but the investigator
does not assign specific interventions to the participants of the study.
Expanded Access:
Records describing the procedure for obtaining an experimental drug or device for patients who
are failing on currently available treatments for their condition and also are unable to
participate in ongoing clinical trials. Expanded Access records are used to register all
types of non-protocol access to experimental treatments, including protocol exception,
single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.
Study Results
Searches can be restricted to studies with or without results.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
Recruitment Status
Also known as Enrollment Status.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Search Terms
Use this box to specify general search terms found anywhere in the trial record.
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Help for Searching clinical trials
Help Topics:
Basic Search:
On the Basic Search page, enter a word or word(s) that you want to use to find studies.
These may include diseases, interventions, and/or locations.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
Use of a Pacemaker Following a Heart Attack.
higher than the study,
Heart Defects and Transient Ischemic Attacks
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Advanced Search:
Many searches are a single term and can be performed with a few words in the
search box. But, sometimes you need more control. Click on the Advanced Search tab
(if starting a new search) or Refine Search tab (if modifying an existing search)
to show additional search fields.
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Recruitment:
Interventions:
Outcomes Measures:
Sponsor/Collaborators:
Sponsor (Lead):
Study IDs:
Country/State:
Location Terms:
Gender:
Age Group:
Phase:
Funded By:
Safety Issue:
First Received:
Last Updated:
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Performs a general search in all sections of the study record, including title,
description, conditions, interventions, locations, etc. Terms in this field are
searched the same as Basic Search.
Recruitment:
Limits search results to studies that are open or closed. New volunteers may be
able to participate in open studies, but not closed studies.
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Study Results:Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Values are color coded (as shown) in the search results.
Limits search results based on whether the study has results or not:
Study Type:
All Studies,
Studies With Results, or
Studies Without Results
The inclusion of Study Results is a new feature of ClinicalTrials.gov.
Only a few studies have results available.Studies With Results, or
Studies Without Results
Limits search results to any of the following study types:
Conditions:
Interventional,
Observational, or
Expanded Access
Observational, or
Expanded Access
Performs a search on fields describing the diseases or conditions being studied.
Interventions:
Performs a search on fields listing the drugs or interventions being studied.
Outcomes Measures:
Performs a search on fields listing the outcome measures used to quantify study results.
Sponsor/Collaborators:
Performs a search on fields listing the sponsor and collaborators of a study.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Sponsor (Lead):
Performs a search on the sponsor field of a study.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Study IDs:
Performs a search on fields listing ID numbers.
Country/State:
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state (e.g., United States, Alabama).
Location Terms:
Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic).
Not all studies include this level of detail, but if they do, this will find them.
Gender:
Limits search results to those studies that accept female or male participants.
Age Group:
Limits search results to those studies that include at least one of the specified age
ranges. More than one age group can be selected.
Phase:
Limits search results to studies that are labeled with at least one of the specified
phases. More than one Phase can be selected.
Funded By:
Limits search results to studies that have at least one sponsor of the specified types.
More than one sponsor type can be selected.
Safety Issue:
Limits search results to studies that have at least one outcome measure designated as a safety issue.
First Received:
Limits search results to studies that were received by clinical trials within a
specified date range. The "From" or "To" field can be left blank.
Last Updated:
Limits search results to studies that were modified within a
specified date range. The "From" or "To" field can be left blank.
Refine Search:
Searches display a list of studies found (List Results tab). If you are not content with
the search results, click on the Refine Search tab at the top of the list to modify your
search.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
When you are done making changes, click Search to display the new results.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
When you are done making changes, click Search to display the new results.
Search Expressions:
Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.
For example:
prostate cancer AND radiation
heart disease AND stroke AND California
heart disease AND stroke AND California
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Aspirin OR ibuprofen
heart disease OR heart attack
heart disease OR heart attack
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Immunodeficiency NOT AIDS
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )
( heart disease OR heart attack ) AND ( stroke OR clot )
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
Ear, Nose, and Throat Conditions
is the expression
( Ear OR Nose OR Throat ) AND Conditions
Fortunately, search will do a pretty good job of finding the right studies either way.To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.